Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
WBBM Radio Chicago on MSN4d
Newly approved pain med offers 'huge' potential, local doctor saysThe new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
MyChesCo on MSN4d
FDA Approves First-in-Class Non-Opioid Pain Drug JournavxThe U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback